OBJECTIVE: In this study, we investigated whether regular use of aspirin or acetaminophen was associated with risk of cervical cancer in women treated at an American cancer hospital. METHODS: This case-control study included 328 patients with cervical cancer and 1,312 controls matched on age and decade enrolled. Controls were women suspected of having but not ultimately diagnosed with a neoplasm. Analgesic use was defined as regular (at least once per week for ≥6 months), frequent (≥7 tablets/week), very long term (≥11 years), or frequent, long term (≥7 tablets per week for ≥5 years). RESULTS: Compared to nonusers, frequent aspirin use was associated with decreased odds of cervical cancer (odds ratio, 0.53; 95% confidence interval, 0.29-0.97). A slightly larger association was observed with frequent, long-term use of aspirin (odds ratio, 0.46; 95% confidence interval, 0.22-0.95). Acetaminophen use was not associated with the risk of cervical cancer. CONCLUSIONS: Our findings suggest that frequent and frequent, long-term use of aspirin is associated with decreased odds of cervical cancer. To our knowledge, this is the first US-based study examining these associations. Given the widespread use of nonsteroidal anti-inflammatory drugs and acetaminophen worldwide, further investigations of the possible role of analgesics in cervical cancer, using a larger sample size with better-defined dosing regimens, are warranted.
OBJECTIVE: In this study, we investigated whether regular use of aspirin or acetaminophen was associated with risk of cervical cancer in women treated at an American cancer hospital. METHODS: This case-control study included 328 patients with cervical cancer and 1,312 controls matched on age and decade enrolled. Controls were women suspected of having but not ultimately diagnosed with a neoplasm. Analgesic use was defined as regular (at least once per week for ≥6 months), frequent (≥7 tablets/week), very long term (≥11 years), or frequent, long term (≥7 tablets per week for ≥5 years). RESULTS: Compared to nonusers, frequent aspirin use was associated with decreased odds of cervical cancer (odds ratio, 0.53; 95% confidence interval, 0.29-0.97). A slightly larger association was observed with frequent, long-term use of aspirin (odds ratio, 0.46; 95% confidence interval, 0.22-0.95). Acetaminophen use was not associated with the risk of cervical cancer. CONCLUSIONS: Our findings suggest that frequent and frequent, long-term use of aspirin is associated with decreased odds of cervical cancer. To our knowledge, this is the first US-based study examining these associations. Given the widespread use of nonsteroidal anti-inflammatory drugs and acetaminophen worldwide, further investigations of the possible role of analgesics in cervical cancer, using a larger sample size with better-defined dosing regimens, are warranted.
Authors: Julie A Baker; Joli R Weiss; Myron S Czuczman; Ravi J Menezes; Christine B Ambrosone; Kirsten B Moysich Journal: Cancer Causes Control Date: 2005-04 Impact factor: 2.506
Authors: H T Sørensen; S Friis; B Nørgård; L Mellemkjaer; W J Blot; J K McLaughlin; A Ekbom; J A Baron Journal: Br J Cancer Date: 2003-06-02 Impact factor: 7.640
Authors: James Brian Szender; Rikki Cannioto; Nicolas R Gulati; Kristina L Schmitt; Grace Friel; Albina Minlikeeva; Alexis Platek; Emily H Gower; Ryan Nagy; Edgar Khachatryan; Paul C Mayor; Karin A Kasza; Shashikant B Lele; Kunle Odunsi; Kirsten B Moysich Journal: J Low Genit Tract Dis Date: 2016-07 Impact factor: 1.925
Authors: Rikki Cannioto; John Lewis Etter; Lauren Beryl Guterman; Janine M Joseph; Nicholas R Gulati; Kristina L Schmitt; Michael J LaMonte; Ryan Nagy; Albina Minlikeeva; James Brian Szender; Kirsten B Moysich Journal: Cancer Epidemiol Date: 2017-05-18 Impact factor: 2.984
Authors: Rikki Cannioto; John Lewis Etter; Michael J LaMonte; Andrew D Ray; Janine M Joseph; Emad Al Qassim; Kevin H Eng; Kirsten B Moysich Journal: Cancer Treat Res Commun Date: 2018
Authors: Simona Roxana Georgescu; Cristina Iulia Mitran; Madalina Irina Mitran; Constantin Caruntu; Maria Isabela Sarbu; Clara Matei; Ilinca Nicolae; Sandra Milena Tocut; Mircea Ioan Popa; Mircea Tampa Journal: J Immunol Res Date: 2018-08-27 Impact factor: 4.818